60 Degrees Pharmaceuticals (SXTP) Invested Capital (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has reported Invested Capital for 4 consecutive years, with $8772.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Invested Capital changed 0.0% year-over-year to $8772.0; the TTM figure through Mar 2026 stood at $8772.0 (changed 0.0% YoY), while the FY2025 annual figure was $8772.0, changed 0.0% from the prior year.
• Invested Capital held at $8772.0 in Q4 2025 per SXTP's latest filing, from $8772.0 in the prior quarter.
• Across five years, Invested Capital topped out at $23.5 million in Q2 2023 and bottomed at $8772.0 in Q1 2024.
• Historically, Invested Capital has averaged $4.6 million across 4 years, with a median of $11211.0 in 2023.
• Annual changes were most pronounced in 2023 — Invested Capital sank 99.68% — and 2025, when it changed 0.0%.
• 60 Degrees Pharmaceuticals' Invested Capital stood at $4.3 million in 2022, then tumbled by 99.68% to $13650.0 in 2023, then slumped by 35.74% to $8772.0 in 2024, then changed by 0.0% to $8772.0 in 2025.
• Business Quant data shows SXTP's Invested Capital at $8772.0 in Q4 2025, $8772.0 in Q4 2024, and $8772.0 in Q1 2024.